Status:
COMPLETED
Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Cardiomyopathy
Arrhythmogenic Right Ventricular Dysplasia
Eligibility:
All Genders
10+ years
Brief Summary
The purpose of this trial is to study the genetic and phenotypic aspects of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C), and determine the impact of genetic testing in clinical ...
Detailed Description
Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/ARVC), is an inherited myocardial disease that predominantly affects the right ventricle (RV) and the estimated prevalence in the genera...
Eligibility Criteria
Inclusion
- Patient with DVDA diagnostic confirmed
- Acceptance even follow-up
- Informed consent
Exclusion
- Impossible to understand the notice information about study
- Not affiliated with social protection
Key Trial Info
Start Date :
September 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2013
Estimated Enrollment :
351 Patients enrolled
Trial Details
Trial ID
NCT00999947
Start Date
September 1 2006
End Date
March 1 2013
Last Update
November 25 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pitié-Salpêtrière Hospital
Paris, France, 75013